Moreover, SIRT7 inactivation in Hep3B cells caused a strong reduction of in vivo tumor growth rate and tumor size, confirming the same molecular alterations observed in vitro, hypothesizing sirtuin-7 targeting or miR-125a/b restoration as possible therapeutic strategies in HCC. This evidence concerns the gene SIRT7 and hepatocellular carcinoma.